Welcome to the third installment in our video series highlighting the ways that Cystic Fibrosis Foundation Therapeutics (CFFT) and industry are tackling cystic fibrosis from every angle. This week's topic explores new approaches to restoring airway surface liquid that are in CFFT's drug development pipeline.
Watch the video below to hear Dr. John P. Clancy describe how the airway surfaces in the lungs of people with CF become dehydrated and why it is important to restore liquid to those surfaces. Dr. Clancy describes two new research approaches being tested in clinical trials that may help correct this problem.
If you haven't already, check out the previous posts on restoring CFTR function and reducing inflammation. And stay tuned for more videos about ongoing research.
To learn more about drugs that are in development, visit our drug development pipeline. Or if you would like to search for a clinical trial, visit the Clinical Trial Finder.
